Litcius/Paper detail

Does Metformin Interfere With the Cardiovascular Benefits of SGLT2 Inhibitors? Questions About Its Role as the Cornerstone of Diabetes Treatment

Milton Packer

2020The American Journal of Medicine17 citationsDOI

Topics & Concepts

MetforminMedicineUnited Kingdom Prospective Diabetes StudyType 2 diabetesDiabetes mellitusInternal medicineOverweightIntensive care medicineEndocrinologyBody mass indexDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerDiabetes Management and Research
Does Metformin Interfere With the Cardiovascular Benefits of SGLT2 Inhibitors? Questions About Its Role as the Cornerstone of Diabetes Treatment | Litcius